Log in with your email address username.


[Correspondence] The ABC risk score for patients with atrial fibrillation – Authors’ reply

We thank the correspondents for their comments on our Article1 concerning the new biomarker-based age, biomarkers, and clinical history (ABC)-bleeding risk score in patients with atrial fibrillation. The biomarker field has matured greatly in recent years and acquired increased notice also in clinical cardiology guidelines.2 Apart from the robust methods by which the ABC-bleeding risk score was developed and validated, another key advantage of the score is easy adaptability, in terms of use and future refinement.